NCT04469868

Brief Summary

Opioid analgesics are routinely prescribed for these patients for post-operative pain control. Even a short exposure to opioids in opioid-naïve patients following minor or major surgery has been associated with de novo habitual or persistent use of opioids in 5-30% of patients. The goal of the study to eliminate the use of outpatient opioids prescriptions after major urologic surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
350

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 15, 2018

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

July 8, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 14, 2020

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2024

Completed
Last Updated

July 31, 2024

Status Verified

July 1, 2024

Enrollment Period

5.2 years

First QC Date

July 8, 2020

Last Update Submit

July 30, 2024

Conditions

Keywords

OpioidsPrescriptionsSurgeryRecoveryPain score

Outcome Measures

Primary Outcomes (2)

  • Opioids prescribing at hospital discharge

    Patients will be discharged with no or few opioids after surgery along with instruction on how to use non-opioid analgesic measures.

    30 days

  • All opioids prescriptions within 30 days of surgery

    The electronic medical records and pharmacy records will be monitored to identify if any additional opioids prescriptions were provided by any provider

    30 days

Secondary Outcomes (3)

  • Post-operative pain after discharge

    7 days

  • Satisfaction score during home recovery

    7 days

  • Contact with healthcare facilities

    30 days

Study Arms (1)

No opioids prescriptions at discharge

EXPERIMENTAL

Patients will receive non-opioid analgesia, mostly over the counter, medications such as acetaminophen or ibuprofen. Opioids may be prescribed if the patients experience break through pain and call the office.

Behavioral: No opioids at discharge

Interventions

Patients who are being scheduled for any major urologic cancer surgery (open or laparoscopic) will be counselled regarding post-operative pain and measures taken during surgery and during hospital stay. They will be provided written information on these pain mitigation efforts and the adverse effects associated with opioids use and outpatient prescriptions. Patients will be discharged from the hospital without any opioids prescriptions and instructions to use non-opioids analgesics. Patients will complete a visual analog pain scale daily for 7 days after discharge from the hospital. Patients will be able to call the clinic at anytime for any post-operative pain issues.

No opioids prescriptions at discharge

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients undergoing major urologic cancer surgery, either open or laparoscopic, will be included in the study.
  • This will include all open or laparoscopic or robotic surgery including radical prostatectomy, radical cystectomy, radical nephrectomy, partial nephrectomy, nephron-ureterectomy, and similar procedures.

You may not qualify if:

  • Those with allergy or intolerance to NSAIDS may be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Albany Medical Center

Albany, New York, 12208, United States

Location

MeSH Terms

Conditions

Substance-Related DisordersPain, Postoperative

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental DisordersPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Badar Mian, MD

    Albany Medical College

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: All patients who undergo major urologic oncology surgery will be eligible to be enrolled.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Surgery

Study Record Dates

First Submitted

July 8, 2020

First Posted

July 14, 2020

Study Start

December 15, 2018

Primary Completion

March 1, 2024

Study Completion

April 1, 2024

Last Updated

July 31, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations